4Filed Jul 26, 8:00 PM ET
USANA (USNA) Director Ding Xia Converts 1,632 RSUs; 604 Withheld
$USNA · USANA HEALTH SCIENCES INCResearch Summary
AI-generated summary of this SEC filing
USANA (USNA) Director Ding Xia Converts 1,632 RSUs; 604 Withheld
What Happened
- Ding Xia, a director of USANA Health Sciences (USNA), had 1,632 restricted stock units (RSUs convert/derivative) vest on July 23, 2026. Per the filing, 604 of those shares were withheld to cover tax withholding at $20.92/share (≈ $12,636), leaving a net 1,028 shares delivered to Ding.
- This was a vesting/award conversion (reported as derivative exercise/conversion and a tax-withholding disposition), not an open-market purchase or sale.
Key Details
- Transaction date: July 23, 2026. Form 4 filed July 27, 2026 (timely).
- Recorded entries: two derivative conversion (code M) entries for 1,632 RSUs and a tax-withholding (code F) of 604 shares at $20.92/share ($12,635.68 reported as $12,636).
- Net shares received: 1,028 (1,632 vested − 604 withheld).
- Shares owned after transaction: not specified in the filing.
- Footnotes: F1 clarifies each RSU equals one contingent share; F2 shows the RSUs vest 25% on Jul 23, 2026, Oct 22, 2026, Jan 21, 2027, and Apr 22, 2027 — the 1,632 shares represent the 25% tranche (implying a total grant of 6,528 RSUs).
Context
- This was a routine equity-compensation vesting event. The withholding of 604 shares to cover tax liabilities is a common, non-dispositive step (cashless-type settlement for taxes) and does not by itself indicate buying or selling intent in the market.
- For retail investors: purchases are generally considered stronger signals than routine vesting; this filing documents compensation delivery rather than a market trade.